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ABSTRACT
The development of DBA/2J mouse strain embryos is nearly 12 h - or 6 somite pairs - delayed as compared 
to the outbred NMRI mouse embryos of the same age on gestation days (GD) 8-12. To evaluate inter-
strain differences in susceptibility to teratogens, dams were treated with methylnitrosourea (MNU, 5 
mg/kg body weight i.p.) on defined gestation days (NMRI: GD 9, 91/2 or 10; DBA/2J: GD 10 or 101/2). 
Skeletal anomalies produced by MNU on both mouse strains varied with the GD of treatment. The pattern 
of anomalies produced by MNU on a given GD markedly differed between the two mouse strains, yet 
they were similar –with a few exceptions- when exposures at equivalent embryonic stages are compared. 
Findings from this study indicated that strain-dependent differences in the developmental stage of mouse 
embryos of the same gestational age occur, a possibility that has been often neglected when inter-strain 
differences in susceptibility to developmental toxicants are interpreted. 
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INTRoDuCTIoN
The phase specificity of teratogens, or the idea that 
the susceptibility to teratogenic agents varies with 
the developmental stage at the time of exposure, is 
one of the principles of teratology enunciated by 
James Wilson over 50 years ago (Wilson 1959). 
It was demonstrated by Stockard’s pioneering 
studies on the “critical periods” of vulnerability 
of fish (Fundulus sp.) embryos to teratogens 
(Stockard 1921), and further substantiated by 
several mammalian studies in which mothers were 
exposed to toxicants at a sequence of defined stages 
of embryo development (Frohberg 1969, Shenefelt 
1972, Horton et al. 1985, Cherrington and Chernoff 
2002). Along this line, the classical work by Clarke 
Fraser on the susceptibility to cleft palate in A/Jax 
and C57BL mice was one of the earliest studies to 
illustrate phase specificity principle in mammalian 
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embryos (Clarke Fraser 1977). Clarke Fraser noted 
that the shelves moved to a horizontal position 
later in A/Jax than in C57BL embryos thereby 
making the former strain embryos relatively more 
susceptible than the latter to any environmental 
factor that delays shelf movement. The phase 
specificity of developmental toxicants was also 
illustrated by Nowack’s characterization of human 
pregnancy periods of susceptibility to thalidomide-
induced embryopathy (Nowack 1965).
Owing to phase specificity, the developmental 
stages at which embryos are exposed are taken into 
account when teratogenic effects are extrapolated 
between species. Moreover, it is known that, in 
polytocous mammals, the stage of development 
of individual embryos varies within the litter 
and between litters at a same gestational age. 
Nonetheless, a strain-dependent difference in the 
development of embryos of the same age has seldom 
been considered as a possible cause for inter-strain 
differences in susceptibility to teratogens (Linval 
et al. 1982, Moreno and Epstein 1987, Biddle 
1988, Juriloff et al. 1991, Biddle et al. 1993, Hall 
et al. 1997, Datta et al. 2008, Downing et al. 2010). 
Along this line, it should be mentioned that a 
comparative study of the embryo development in 
four mouse strains (NMRI, BALB/cJ, DBA/2J and 
C57BL/6J) revealed remarkable differences among 
them in somite counts on defined gestation times 
(GD) between GD9 and GD12 (Thiel et al. 1993). 
Additionally, it was also noted that, for a given 
mouse strain on a same GD, there was a pronounced 
variability of somite counts within and between 
litters (Thiel et al. 1993). Inter-strain differences 
on the average number of somite pairs of embryos 
of the same gestational age were clearly shown by 
the aforementioned comparative study (Thiel et al. 
1993). 
In this study we investigated the hypothesis 
that the development of outbred NMRI and 
inbred DBA/2J mouse embryos does not proceed 
synchronously and that, owing to this fact, distinct 
patterns of skeleton anomalies would occur after 
pregnancy-timed exposures to methylnitrosourea 
(MNU) during organogenesis (GD8-12). Since 
one pair of somites develops in nearly 2 h in rats 
and mice (Vickers 1983, Goedbloed and Smits-van 
Prooije 1986), we used a DNA-alkylating teratogen 
(MNU) with a very short half-life (t1/2 <15 min) 
(Swann 1968) so that the length of exposure of 
individual embryos was much shorter than the time 
needed for the development of a somite pair.
MATERIAlS AND METhoDS
ANIMALS
The inbred DBA/2J and outbred NMRI mice used 
in this study were supplied by the Zentralinstitute 
für Versuchstierzucht, Hannover, Germany. The 
animals were kept under specific pathogen free 
(spf) conditions with free access to a standard 
rodent pellet diet (Altromin® 1324, Fa Altromin 
Lage, Germany) and tap water. Animals` quarters 
photoperiod (lights on from 09:00 a.m. to 9:00 
p.m.), temperature (21±1ºC), and relative humidity 
(55±5%) were controlled. All mice were adapted 
to the conditions of our animal facilities for 3 
weeks before being used in experiments. Animals 
received humane care and protocols complied with 
institutional (Charité - Universitätsmedizin Berlin) 
and legal guidelines. 
MATING PROCEDURE
Five untreated virgin females were placed into the 
cage of one male for 2 h each day (07:00-09:00 
a.m.) and subsequently examined for the presence 
of a vaginal plug. The first 24 h period following 
the detection of a vaginal plug was considered as 
gestation day (GD) 0.  Females which were treated 
or scored for somite numbers on days 91/2 or 101/2 
were mated between 07:00 p.m. and 09:00 p.m.. At 
the time of mating, body weights of DBA/2J and 
NMRI mice ranged from 20 to 25 g, and from 30 to 
35 g, respectively.
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TREATMENT
N-Methyl-N-nitrosourea (MNU, CAS Nr 684-
93-5) was purchased from Sigma Chemical Co. 
Since MNU decomposes substantially faster with 
increasing pH values, it was dissolved in saline 
phosphate buffer at pH 5 immediately before being 
administered to mice. To exclude any possibility of 
a circadian variation in the teratogenic response, 
all treated mice were injected with MNU at 9:00 
a.m. Based on previous data on the dose response 
relationships of embryotoxic effects of MNU in 
mice (Platzek et al. 1988), we chose a dose as high as 
5 mg/ kg body weight, given by the intraperitoneal 
route, for this study. The injection volume was 10 
μL per g of body weight.
DETERMINATION OF THE NUMBER OF SOMITES
For counting somite pairs, pregnant females were 
killed by cervical dislocation at 9:00 a.m., the 
NMRI dams on gestation days (GD) 8, 9, 91/2, 10, 
101/2, 11 and 12, and the DBA/2J dams on GD9, 10, 
101/2, 11 and 12. Immediately after death, uteri were 
opened, implantation sites were recorded and all 
living embryos were removed and examined under 
a stereomicroscope with 40-fold magnification. 
The yolk sac was carefully removed and embryos 
were illuminated with a white light for determining 
the number of somite pairs. Only undamaged 
embryos with completely developed somites were 
evaluated.     
EVALUATION OF FETAL SKELETON ANOMALIES
For evaluating the skeleton anomalies caused by 
pregnancy-timed exposures to MNU, untreated 
controls and MNU-treated dams were killed by 
cervical dislocation on GD18 at 9:00 a.m.. The 
gravid uterus was weighed, opened and examined to 
determine the number of implantations, and living, 
dead and resorbed fetuses. Fetuses were removed 
from the uterus, blotted, weighed, examined for 
externally-visible abnormalities and fixed in a 5% 
buffered formaldehyde solution. After fixation, 
fetuses were cleared and stained with alizarin red S 
for skeleton evaluation. 
STATISTICAL ANALYSIS 
Statistical evaluation was performed using a SAS 
statistical software package (SAS Institute, SAS 
User`s Guide, SAS Institute, Cary, NC, USA). 
Parametric variables were analyzed by ANOVA 
and Duncan`s post hoc test. A non-parametric 
test (Mann-Whitney U test) was used to compare 
somite counts between NMRI and DBA/2 mice. 
Proportions were compared by the Fisher exact 
test or by chi-square test. In any case, differences 
were considered as statistically significant when P 
< 0.05.
RESulTS AND DISCuSSIoN
DEVELOPMENT OF SOMITES OF NMRI AND DBA/2J 
MOUSE EMBRYOS ON GD8-12. 
As shown in Table I, the number of somite pairs 
steadily increased during the embryo development 
between GD8 and GD12 in both mouse strains. 
The mean of the number of somite pairs of DBA/2J 
embryos was lower (Mann-Whitney U test, P<0.05) 
than that of NMRI embryos at GD9, 10, 101/2, 11 and 
12 (Table I). Nonetheless, DBA/2J embryos somite 
pair means on GD10 and 101/2 were comparable 
to those of NMRI embryos half a day earlier, 
i.e., on GD91/2 and 10, respectively (Table I). The 
foregoing data indicated that the development of 
DBA/2J embryos was – on average - approximately 
12 hours delayed as compared to the development 
of NMRI embryos of the same age. The length 
of the development delay of DBA/2J embryos 
compared to NMRI embryos was 5 somite pairs on 
GD9, 6.8 on GD10, 7.6 on GD101/2, 4.6 on GD11 
and 4.5 on GD12, or an average 5.7 somite pairs 
difference during the GD9-12 period. Therefore, 
the 12 h development difference between DBA/2J 
and MNRI embryos corresponds to an average 
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somite count of nearly 6. The foregoing estimate of 
the length of the developmental delay of DBA/2J 
embryos as compared to NMRI embryos of the 
same gestation age is consistent with previous 
estimates that, in rats and mice, one pair of somites 
develops in approximately 2 h (Vickers 1983, 
Goedbloed and Smits-van Prooije 1986). Since 
organogenesis proceeds very fast on GD8-12, such 
an inter-strain difference of nearly 6 somite pairs 
in embryo development at a defined gestation time 
(GD) is expected to result in distinct responses to 
short exposures to a developmental toxicant. 
It is of note that, in the outbred (NMRI) mouse 
breeding stock as well as in the inbred (DBA/2J) 
mouse strain, somite pair counts at a defined GD 
exhibited a marked variation so that, for a same 
strain, ranges of individual somite counts overlap 
to some extent between two 12 h-apart gestation 
times (GDs) (Table I). The foregoing finding is 
consistent with previous observations that there is 
a considerable within and between litter variation 
of somite counts at defined GDs, irrespective of 
whether mouse strain is outbred or inbred (Thiel 
et al. 1993, van Maele-Fabry et al. 1992). The 
underlying causes for such a wide within litter 
variation of somite counts are not entirely clear. 
Since within-litter variation of somite counts occurs 
in inbred strains as well, it cannot be explained by 
genetic differences among littermates. Random 
differences among embryos in fertilization and/or 
implantation time, and/or differences related to the 
position of the embryo within the uterus can not 
be ruled out as contributing factors for the within-
litter variability of somite pair numbers. 
Differences of copulation time that occur even 
if mating period is limited to a few hours, and other 
maternal factors possibly contribute to the inter-
litter variation of somite counts, while genetic 
and epigenetic factors can not be excluded in the 
case of inter-strain differences. Data provided by 
Ciriani and Diewert (1986) and also by Collins et 
al. (2006) suggested that inter-strain differences 
in somite development may arise from imprinting 
of maternal genes and or from an influence of 
maternal uterine environment. Collins et al. (2006) 
found that crosses between C57BL/6N females 
and SWV males yielded embryos that were more 
developmentally advanced than those produced 
by crosses between SWV females and C57BL/6N 
males. A similar directional dominance toward the 
maternal strain had also been noted by Ciriani and 
Diewert (1986) who made reciprocal intercrosses 
of C57BL/6 and A/WySn mouse strains. Genetic 
imprinting involves methylation and histone 
modifications that lead to monoallelic gene 
expression (Isles and Holland 2005). The idea that 
somite development depends on maternal genes 
that are preferentially expressed in the conceptus is 
plausible because it is known that many imprinted 
genes in mammals are involved in pre and postnatal 
growth as well as in metabolism (Isles and Holland 
2005). Moreover, as commented by Bourc’his 
and Proudhon (2008), experiments involving 
construction - by nuclear transfer - of uniparental 
conceptuses indicated that conceptuses with two 
maternal genomes (parthenogenetic) or with two 
paternal genomes (androgenetic) did not progress 
beyond mid gestation. Furthermore, uniparental 
conceptuses also exhibited an imbalance in 
embryo:placenta growth which depended on the 
parental origin of the nucleus. These studies led 
to the long-standing generalization that maternal 
genome is required for the development of the 
embryo while the paternal genome promotes the 
development of the extraembryonic structures 
(placenta) (Bourc’his and Proudhon 2008).   
A considerable variability in the developmental 
stage among embryos at a given gestational age 
has also been observed in humans and non-human 
primates (Neubert et al. 1988, Shiota 2009). 
Possible causes of such a variation in human 
embryonic development were discussed by Shiota 
(2009) who analyzed Nishimura’s unique collection 
of human embryos with over 44,000 specimens 
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from therapeutic abortuses performed in Japan. 
Although recognizing that inaccurate estimates of 
fertilization time is a contributing factor for the 
developmental variability, Shiota (2009) concluded 
that variability also arises from the fact that prenatal 
development does not proceed at the same speed in 
every embryo
Results presented here and findings from 
previous studies (van Maele-Fabry et al. 1992, Thiel 
et al. 1993) showed that gestation age is an imprecise 
indicator of the developmental stage of rodent 
embryos as well. Although the developmental stage 
of early post-implantation embryos is generally 
defined by number of somite pairs, variations in 
morphological stages of a given structure among 
embryos with the same number of somite pairs 
have been found in NMRI mice (Vickers 1983). 
Taken together these observations illustrate that 
the development of mouse embryos, even that of 
those with an almost identical genotype, proceeds 
differently during the organogenesis period.  
SKELETON ANOMALIES INDUCED BY TIMED 
ExPOSURES TO MNU BETWEEN GD9 AND 101/2 IN 
NMRI AND DBA/2J MICE
 It had been reported that, at the dose level selected 
for this study (5 mg/kg body wt i.p.), MNU induced 
a variety of skeleton defects, while producing no 
or very low embryolethality, and no overt maternal 
toxicity in mice (Platzek et al. 1988). Caesarean 
section data of untreated controls and MNU-
treated dams on GD18 confirmed that this DNA-
alkylating agent, at the tested dose, was not overtly 
embryolethal. As shown in Table II, except for a 
slight increase in the number of resorptions per litter 
(0.22±0.43 vs 0.77±1.31, P=0.04) among DBA/2J 
mice treated on GD10, MNU did not produce any 
other discernible increase in the resorption rate, 
nor did it decrease the litter size (number of live 
fetuses per litter) regardless the mouse strain or the 
GD of treatment (Table II). A significant increase 
in the number of implantations per litter was found 
in NMRI mice treated with MNU on GD10 and 
in DBA/2J mice treated with this alkylating agent 
on GD101/2 (Table II). A larger litter size was also 
detected in the group of DBA/2J mice treated 
with MNU on GD101/2 (Table II). A larger litter is 
consistent with a greater number of implantations 
per litter but the toxicological relevance of these 
findings is unclear. A reduction of fetal body weight 
was observed in the offspring of NMRI mice treated 
on GD10 and in the offspring of DBA/2J treated on 
GD101/2, but not among NMRI and DBA/2J fetuses 
exposed at earlier GDs (Table II). 
The skeleton anomalies produced by this 
sequence of timed exposures to MNU between GD9 
and 101/2 in NMRI and DBA/2J mice are shown in 
Table III. Despite being rapidly eliminated from the 
maternal organism (Swann 1968), a single dose of 
MNU, administered between GD9 and 101/2, caused 
a variety of skeleton anomalies in the offspring of 
NMRI and DBA/2J dams. As expected from phase 
specificity, incidences of most skeleton anomalies 
in both NMRI and DBA/2J mice depended on the 
gestation day (GD) at which the embryos were 
exposed to MNU (Table III). 
Since at a same gestation age (GD) development 
of DBA/2J embryos is nearly 12 h delayed as 
compared to that of NMRI embryos, maximum 
incidences of these anomalies in the two strains 
were in most instances produced by exposures 
at distinct GDs yet similar developmental stages 
(Tables II and III). 
The induction of cleft palate by MNU illustrates 
the aforementioned time-dependent difference 
in susceptibility to a particular type of anomaly. 
The maximum incidences of cleft palate were 
noted in NMRI mice treated on GD10 (89.5%), 
and in DBA/2J mice treated on GD101/2 (62.7%), 
i.e., in embryos which were exposed when their 
average somite counts were 27.7±3.2 and 25.0±2.2, 
respectively (Table III). Strain differences in the 
susceptibility to cleft palate have been reported 
in the literature. Kusanagi (1985), for instance, 
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TABlE II
Caesarean section data of dams from NMRI (outbred) and DBA/2J (inbred) mouse strains treated with a single injection 
of methylnitrosourea (MNu, 5 mg/kg body weight ip)  on a defined time of pregnancy (gestation days 9, 91/2, 10 or 101/2).
Mouse strain: NMRI DBA/2J
Gestation day 








Litters (N) 11 14 22 10 18 30 9
Implantations (N) 130 176 237 144 73 128 56
Implantations/Litter 11.9±2.4 12.5±1.9 10.8±2.9 14.4±2.5* 4.0±2.1 4.2±1.9 6.2±1.9*
Resorptions (N) 5 6 17 10 5 19 5
Resorptions/Litter 0.55±0.82 1.21±3.2 0.82±1.56 1.05±1.16 0.22±0.43 0.77±1.31* 0.56±0.88
Fetuses (N) 125 170 220 134 68 109 51
Fetuses/Litter 11.4±2.5 11.3±3.3 10.0±3.3 13.4±2.5 3.8±2.0 3.4±1.7 5.7±1.5*
Fetal body weight (g) 1.03±0.14 1.04±0.09 0.96±0.15 0.82±0.08* 0.95±0.12 0.71±0.11 0.63±0.08*
Gestation day 0 = first 24 h period after mating. Data are shown as means ± SD and were analyzed – separately for each stock/
strain - by ANOVA and Duncan’s post hoc test.  An asterisk (*) indicates that the mean differs (P<0.05) from that of the untreated 
control from the same strain.
TABlE III 
 occurrence of skeleton anomalies in the offspring of NMRI and DBA/2J mice treated with a single injection of 
methylnitrosourea (MNu, 5 mg/kg body weight ip)  on a defined time of pregnancy (i.e., on gestation days 9, 91/2, 10 or 
101/2). on GD18, all fetuses were removed by C-section and examined for skeleton anomalies after clearing and staining 
with alizarin red S.
Mouse strain: NMRI DBA/2J
Gestation day (GD) at 
treatment (MNu):
untreated
control GD9 GD91/2 GD10
untreated
control GD10 GD101/2
Somite pairs at treatment,  (N, 
mean±SD): - 15.3±2.4 19.0±2.2 27.7±3.2 - 20.9±3.8 25.0 ±2.2
Examined fetuses (N): 125 170 220 134 68 109 51
Anomalies (%) in:
Skull
Cleft palate 0.8 8.2* 10.0* 89.5* 0 22.9* 62.7*
Fontanelle (enlarged) 4.0 4.7 21.8* 93.2* 1.5 27.5* 74.5*
Os zygomaticum (absent) 0 0 0.4 31.3* 0 11.0* 23.5*
(smaller) 0 0 2.3 44.7* 0 9.2* 3.9
Os tympanicum  (fused) 0 0 0 14.9* 0 0 3.9
(shorter) 0 0 0.4 0 0 9.2* 11.7*
Proc.j.Os squamosum (absent) 0 0 0.4 25.3* 0 3.7 15.6*
Os supraoccipitale (absent) 0 0 2.7 14.9* 0 0 0
(smaller) 0 1.8 7.7* 53.7* 0 1.8 0
(misshapen) 9.6 48.2* 39.0* 0 1.5 27.5* 9.8
Os frontale (additional o.c.) 0 3.5 5.4* 0 16.1 26.6* 41.1*
(fused with O.parietale) 0 0 0 0 0 0.9 5.8
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Mouse strain: NMRI DBA/2J
Gestation day (GD) at 
treatment (MNu):
untreated
control GD9 GD91/2 GD10
untreated
control GD10 GD101/2
Somite pairs at treatment,  (N, 
mean±SD): - 15.3±2.4 19.0±2.2 27.7±3.2 - 20.9±3.8 25.0 ±2.2
Vertebral column
Atlas (wider) 0 0 11.8* 0 0 41.2* 43.1*
(misshapen) 2.4 40.5* 20.0* 0.7 0 7.3* 3.9
Thor.ventr. (oc dumbbell ) 0 13.5* 12.2* 4.5 0 16.5* 3.9
Lumb.ventr. (o.c.dumbbell) 0 2.9 7.3* 14.1* 0 31.1* 11.7*
Ribs
(misshapen) 0 2.3 5.9* 11.9* 0 11.9* 0
Cervical (rudimentary, extra) 10.4 0* 28.1* 0* 22.0 59.6* 41.1*
Lumbar (supernumerary) 46.4 55.2 52.2 60.4* 4.4 2.8 0
Sternum
Sternebrae (fused) 0 0 0.4 14.1* 0 6.4* 7.8*
(misaligned) 1.6 6.5* 1.8 0 4.4 1.8 0
(misshapen) 13.6 14.1 38.1* 51.4* 5.9 49.5* 54.9*
(absent) 0.8 1.8 3.6 58.9* 0 24.7 21.5*
½  (fused) 0 1.8 1.4 4.5 0 9.2* 2.0
2/3 (fused) 0 3.5 1.4 0.7 0 0 0
Forelimbs
(misplaced) 0 0 0.9 44.7* 0 8.2* 21.5*
Clavicle (bent) 0 7.6* 4.1* 15.6* 0 25.6* 27.4*
(misshapen) 0 0.6 0 0 0 1.8 3.9
Finger 1 (polydactyly) 0 0.6 0.4 9.0* 0 2.8 0
Finger 2 (polydactyly) 0 0 0.9 14.1* 0 4.6 2.0
(thicker) 0 0 0.4 6.0* 0 4.6 2.0
Fingers ½  (syndactyly) 0 0 0.4 10.4* 0 0.9 0
Forepaws (misplaced) 0 0 0.9 6.7* 0 11.9* 0
Humerus (misshapen) 0  0.4 0.7 0 4.6 0
(absent) 0 0 0 0 0 1.8 0
(shorter) 0 0 0.9 68.6* 0 8.2* 7.8
Metacarpus 2 (absent) 0 0 0.4 3.7 0 2.8 0
Proc.  deltoid (absent) 0 5.3* 10.0* 0.7 0 3.7 5.9
 (smaller) 4.0 10.5* 20.9* 0 0 0.9 0
Radius/humerus (fused) 0 0 0 26.8* 0 1.8 15.6*
Radius (bent) 0 3.5 3.6 30.5* 0 21.1* 27.4*
(absent) 0 0 0.4 3.0 0 0 0
(shorter) 0 0 0.4 76.1* 0 6.4* 15.6*
TABlE III (continuation)
An Acad Bras Cienc (2017) 89 (1 Suppl.)
 SOMITE DEVELOPMENT AND MNU TERATOGENICITY 643
Mouse strain: NMRI DBA/2J
Gestation day (GD) at 
treatment (MNu):
untreated
control GD9 GD91/2 GD10
untreated
control GD10 GD101/2
Somite pairs at treatment,  (N, 
mean±SD): - 15.3±2.4 19.0±2.2 27.7±3.2 - 20.9±3.8 25.0 ±2.2
Scapula (misshapen) 0 0 0.9 18.6* 0 36.6* 11.7*
(absent) 0 0 0 0 0 0.9 0
Spina scapulae (absent) 0 0 0 41.7* 0 25.6* 54.9*
Ulna/humerus  (fused) 0 0 0 22.3* 0 9.2* 17.6*
Ulna/radius/humerus (fused) 0 0 0 32.0* 0 5.5* 13.7*
Ulna/radius (fused) 0 0 0 6.0* 0 6.4* 3.9
Ulna  (bent) 0 0.6 0 11.9* 0 1.8 31.3*
(absent) 0 0 0 18.6* 0 0.9 0
 (shorter) 0 0 0.4 63.4* 0 3.7 23.5*
Hindlimbs
(misplaced) 0 0 1.8 58.2* 0 24.7* 33.3*
(absent) 0 0 0 6.7* 0 4.6 0
Femur (absent) 0 0 0 80.5* 0 42.2* 60.7*
(shorter) 0 2.4 5.0* 9.0* 0 10.0* 11.7*
Fibula (absent) 0 0 0 79.1* 0 16.5* 31.3*
Hindpaws (misplaced) 0 10.0* 2.7 11.9* 0 44.9* 23.5*
Ilium  (absent) 0 0 0 58.2* 0 9.2* 39.2*
Ischium  (fused with os pubis) 0 0 0 39.5* 0 3.7 19.6*
Ischium  (absent) 0 0 0 10.4* 0 1.8 2.0
(shorter) 0 0 16.3* 80.5* 2.9 23.8* 39.2*
Metatarsus 1 (absent) 0.8 2.4 10.0* 23.1* 0 7.3* 2.0
Os pubis  (absent) 0 0 0.4 21.6* 0 3.7 2.0
(shorter) 0 0 16.8* 83.5* 2.9 23.8* 39.2*
Tibia  (bent) 0 1.2 2.7 63.4* 0 32.1* 47.0\*
(absent) 0 2.9 2.7 17.9* 0 3.7 0
(shorter) 0 3.5 3.6 75.3* 0 16.5* 25.4*
Toe 1 (adactyly) 0 1.8 1.4 18.6* 0 2.8 0
(polydactyly) 0 0 0 20.1* 0 4.6 7.8*
Toe 2  (polydactyly) 0 1.2 3.6 21.6* 0 4.6 3.9
Toes ½  (syndactyly) 0 0 5.0 38.8* 0 12.8* 5.9
Proportions (%) different (P<0.05, Fisher exact test) from those of untreated controls of the same strain are indicated by an asterisk 
(*).
TABlE III (continuation)
An Acad Bras Cienc (2017) 89 (1 Suppl.)
644 IBRAHIM CHAHOUD and FRANCISCO J.R. PAUMGARTTEN
showed that horizontalization and fusion of the 
palatal shelves occurred earlier in C57BL/6 than 
in SWV embryos, but fusion of the primary palate 
with the secondary palate occurred later. Owing 
to these differences in the length of susceptibility 
period, C57BL/6 and SWV differed regarding their 
vulnerability to palatal slit and cleft palate induction 
by triamcinolone (Kusanagi 1985). In this study, 
however, frequencies of cleft palate were similar 
in NMRI and DBA/2J mice exposed to MNU at 
equivalent embryonic stages.  
A similar dependency of the effect on the 
embryonic stage at treatment was observed for 
a number of other anomalies induced by MNU 
in both strains such as fontanelle enlarged, os 
zygomaticum absent, Proc. j. os squamosum absent, 
sternebrae anomalies (fused, misshapen, absent), 
forelimbs misplaced, clavicle bent, radius-humerus 
fused, radius bent, radius shorter, scapula spina 
absent, ulna-humerus fused, ulna-radius-humerus 
fused, ulna (bent, shorter), hindlimbs misplaced, 
femur (absent, shorter), fibula absent, ilium absent, 
ischium-os pubis fused, ischium shorter, os pubis 
shorter, and tibia (bent, shorter) (Table III, Figure 
1).  
The foregoing examples are consistent with 
the idea that, provided that NMRI and DBA/2J 
embryos are exposed to MNU at the same 
developmental stage, effects on the occurrence of 
skeleton anomalies are similar between strains.  
Some exceptions, however, were noted. 
Incidences of a few anomalies were enhanced in 
NMRI fetuses exposed to MNU on GD10 (27.7±3.2 
somite pairs), but not in DBA/2J fetuses treated at 
a similar developmental stage (GD101/2, 25.0±2.2 
somite pairs). In NMRI mice, for instance, the 
occurrence of os zygomaticum smaller increased 
from 2.3% on GD91/2 to 44.7% on GD10, while in 
the DBA/2J strain the incidence of this anomaly 
decreased from 9.2% on GD10 to 3.9% on GD101/2 
(Table III). Along the same vein, os supraoccipitale 
absent (14.9%) and smaller (53.7%) were observed 
in NMRI mice treated on GD10, but not in DBA/2J 
treated either on GD10 or on GD101/2 (Table III). 
The incidence of humerus shorter also increased 
from 0.9% (GD91/2) to 68.9% (GD10) in NMRI 
stock, while it remained almost unaltered in 
DBA/2J mice treated at comparable embryonic 
developmental stages (8.2% on GD10 and 7.8% on 
GD101/2) (Table III). Moreover, marked increases 
in the frequencies of hindpaw digit anomalies 
(adactyly, polydactyly and syndactyly) were noted 
among MNRI mice treated on GD10 as compared 
to those treated earlier, while incidences of toe 
anomalies were lower and exhibited only minor 
changes between DBA/2J treated on GD10 and 
those exposed on GD101/2 (Table III). 
A few anomalies, on the other hand, were 
enhanced in DBA/2J mice treated on GD101/2 but 
not in NMRI mice exposed to MNU at a similar 
embryonic stage (GD10).  The frequency of Atlas 
wider, for instance, was substantially increased 
in DBA/2J treated either on GD10 (41.2%) or on 
GD101/2 (43.1%) as compared to untreated control 
incidence (0%), while in the NMRI stock the 
occurrence of this anomaly was 11.8% and 0% after 
treatment on GD91/2 and 10, respectively (Table 
III). In DBA/2J mice, the incidence of hindpaws 
misplaced fell from 44.9% to 23.5% as treatment 
time advanced from GD10 to GD101/2, while in the 
NMRI stock incidences of this anomaly produced 
by treatments at similar embryonic stages were 
2.7% and 11.9%, respectively (Table III). In the 
DBA/2J strain, frequencies of lumbar vertebrae 
o.c. dumbbell-shaped also fell from 31.1% to 
11.7% as treatment time advanced from GD10 to 
GD101/2, while in NMRI mice the incidence of this 
anomaly increased from 7.3% (GD91/2) to 14.1% 
(GD10) with treatments at equivalent embryonic 
developmental stages (Table III).
The aforementioned differences in the 
occurrence of some skeleton anomalies, even 
when NMRI and DBA/2J embryos were exposed 
to MNU at similar developmental stages, suggest 
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Figure 1 - Skeleton anomalies in the hindlimbs induced by 
a single administration of methylnitrosourea (MNU; 5 mg/
kg body weight, ip) to NMRI and DBA/2J mice on gestation 
day (GD) 9, 91/2, 10 or 101/2. Fetuses (GD18) were cleared and 
stained with alizarin red S for skeleton evaluation. Femurs on 
the right side of each photo are indicated by an arrow. Right 
and left femurs are missing in fetuses exposed to MNU on 
GD10 and 101/2 but not in those treated earlier. Os pubis fused 
with os ischium (*) is noted in NMRI fetuses treated on GD10 
and in DBA/2J fetuses treated on GD101/2, while tibia bones 
are bent (#) in fetuses treated on GD10 and 101/2.  C: untreated 
controls. GD0= 24 h period following copulation.
that periods of susceptibility to these anomalies 
possibly also differ between the strains.
Collins and coworkers (Collins et al. 2006, 
Lee et al. 2010) reported inter-strain differences 
in the response to all-trans-retinoic acid that 
cannot be attributed simply to differences in 
either embryo developmental stage at the time of 
exposure, or kinetics of the teratogenic agent. The 
authors noted that, although exhibiting an almost 
identical number of somites at treatment on GD 
9.5, C57BL/6N mice were more susceptible than 
SWV mice to induction of forelimb ectrodactyly 
(missing digits), whereas the opposite was noted 
for the induction of thymus agenesis, gastroschisis 
and cleft palate (Collins et al. 2006). A locus on 
mouse chromosome 11 (Rafar) was found to be 
associated with the difference between C57BL/6N 
and SWV strains susceptibility to all-trans-retinoic 
acid induced forelimb ectrodactyly (Lee et al. 
2005). Furthermore, it was also found that the 
C57BL/6N mouse strain is susceptible, whereas 
SWV strain is resistant to induction of forelimb 
ectrodactyly by CdCl2 (4 mg/kg ip) on GD 9 
[30]. By using a proteomic approach Chen et al. 
(2008) noted that, 24 h after CdCl2 administration 
(GD 10), 38 proteins had identifiable differences 
in abundance levels in cadmium-treated limb 
buds between the two strains. Since of those 38 
proteins, 14 could be associated with the unfolded 
protein response process and 7 are associated 
with actin polymerization, Chen et al. (2008) 
advanced a hypothesis that the differential murine 
strain response to cadmium-induced forelimb 
defects results from differences in their pathways 
for the unfolded protein response and / or actin 
polymerization. 
A study by Downing et al. (2010) also found 
differences in the teratogenic response of C57BL/6J 
and DBA/2J mice to a single dose of valproic acid 
given on GD 9, i.e., while C57BL/6J fetuses were 
more susceptible than DBA/2J fetuses to induction 
of digit (fused or missing digits) and vertebral 
anomalies (fused, missing and asymmetrical arches 
and centra), the latter strain was more susceptible 
than the former mouse strain for the induction of rib 
anomalies (fused, missing, bifurcated, and wavy/
bulbous ribs). Since the authors did not determine 
the number of somite pairs, inter-strain differences 
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of developmental stages at the time of treatment 
cannot be ruled out as contributing factors for 
these differences in susceptibility to VPA-induced 
teratogenicity. Actually, Thiel et al. (1993) reported 
that C57BL/6J embryos are at a more advanced 
stage of development than DBA/2J embryos of the 
same gestation age on GDs 9-12.      
Treatments with MNU between GD9 and 
GD101/2 had only a minor impact on the incidence 
of cervical rudimentary ribs as well as lumbar 
supernumerary ribs, skeleton variations that occur 
spontaneously at relatively high rates in these 
mouse strains (Table III). 
CoNCluSIoNS
Data from this study showed that the effect of 
MNU on the occurrence of skeleton anomalies 
varied with the gestation time (GD) at which NMRI 
and DBA/2J mice were treated. Furthermore, 
a comparison between the two mouse strains 
demonstrated that, at all gestation times analyzed in 
this study (GD8-12), the development of DBA/2J 
embryos was nearly 12 h -or 6 somite pairs- delayed 
as compared to the developmental stage of NMRI 
embryos. Since on GD8-12 embryo development 
-as indicated by somite counts- proceeds differently 
in the two mouse strains, the teratogenic effects 
of MNU on NMRI and DBA/2J fetuses were not 
comparable when treatments took place at the same 
gestation time. Except for a few cases, occurrences 
of fetal skeleton anomalies were similar when 
NMRI and DBA/2J mice had been exposed to 
MNU at equivalent embryonic developmental 
stages. The aforementioned findings highlighted 
that inter-strain differences in susceptibility to 
teratogenic agents may eventually result from 
distinct developmental stages of the strains at a 
same gestation time, a possibility that has been 
often neglected when inter-strain differences in 
susceptibility to developmental toxicants are 
interpreted. 
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